{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:26:21Z","timestamp":1789262781180,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000594","name":"Daiwa Anglo-Japanese Foundation","doi-asserted-by":"publisher","award":["8216\/12167"],"award-info":[{"award-number":["8216\/12167"]}],"id":[{"id":"10.13039\/501100000594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> More data-driven evidence is needed on the cost of antibiotic resistance. Both Japan and England have large surveillance and administrative datasets. Code sharing of costing models enables reduced duplication of effort in research.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To estimate the burden of antibiotic-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> bloodstream infections (BSIs) in Japan, utilizing code that was written to estimate the hospital burden of antibiotic-resistant <jats:italic>Escherichia coli<\/jats:italic> BSIs in England. Additionally, the process in which the code-sharing and application was performed is detailed, to aid future such use of code-sharing in health economics.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> National administrative data sources were linked with voluntary surveillance data within the Japan case study. R software code, which created multistate models to estimate the excess length of stay associated with different exposures of interest, was adapted from previous use and run on this dataset. Unit costs were applied to estimate healthcare system burden in 2017 international dollars (I$).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Clear supporting documentation alongside open-access code, licensing, and formal communication channels, helped the re-application of costing code from the English setting within the Japanese setting. From the Japanese healthcare system perspective, it was estimated that there was an excess cost of I$6,392 per <jats:italic>S. aureus<\/jats:italic> BSI, whilst oxacillin resistance was associated with an additional I$8,155.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold><jats:italic>S. aureus<\/jats:italic> resistance profiles other than methicillin may substantially impact hospital costs. The sharing of costing models within the field of antibiotic resistance is a feasible way to increase burden evidence efficiently, allowing for decision makers (with appropriate data available) to gain rapid cost-of-illness estimates.<\/jats:p>","DOI":"10.3389\/fpubh.2020.562427","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T04:40:48Z","timestamp":1606452048000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Code-Sharing in Cost-of-Illness Calculations: An Application to Antibiotic-Resistant Bloodstream Infections"],"prefix":"10.3389","volume":"8","author":[{"given":"Nichola R.","family":"Naylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kunisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Castro-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheelah","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1086\/651110","article-title":"Estimating the Cost of health care\u2013associated infections: mind your p's and q's","volume":"50","author":"Graves","year":"2010","journal-title":"Clin Infect Dise."},{"key":"B2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cmi.2017.06.011","article-title":"Is antimicrobial stewardship cost-effective? A narrative review of the evidence","volume":"23","author":"Naylor","year":"2017","journal-title":"Clin Microbiol Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"30319","DOI":"10.2807\/1560-7917.ES.2016.21.33.30319","article-title":"The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study","volume":"21","author":"Stewardson","year":"2016","journal-title":"Euro Surveill."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e179767","DOI":"10.1371\/journal.pone.0179767","article-title":"Estimating the disease burden of methicillin- resistant Staphylococcus aureus in Japan : retrospective database study of Japanese hospitals","volume":"12","author":"Uematsu","year":"2017","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/bimj.201100222","article-title":"Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections","volume":"54","author":"Coeurjolly","year":"2012","journal-title":"Biom J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jhin.2014.08.008","article-title":"Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach","volume":"88","author":"van Kleef","year":"2014","journal-title":"J Hosp Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jpids\/piu073","article-title":"Quantifying the burden of hospital-acquired bloodstream infection in children in England by estimating excess length of hospital stay and mortality using a multistate analysis of linked, routinely collected data","volume":"4","author":"Green","year":"2015","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0221944","DOI":"10.1371\/journal.pone.0221944","article-title":"The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: a national retrospective cohort study","volume":"14","author":"Naylor","year":"2019","journal-title":"PLoS ONE."},{"key":"B10","unstructured":"The Comprehensive R Archive Network.2020"},{"key":"B11","unstructured":"GitHubInc\n          GitHub.2020"},{"key":"B12","unstructured":"Signposting Health Economic Packages in R for Decision Modelling (SHEPRD).2020"},{"key":"B13","unstructured":"GreenN\n          Health Economics R Packages.2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhin.2018.06.026","article-title":"Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus. infections in Japan and England","volume":"100","author":"Mizuno","year":"2018","journal-title":"J Hosp Infect."},{"key":"B15","unstructured":"Hospital burden\n            NaylorNR\n          GitHub.2017"},{"key":"B16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jval.2010.09.008","article-title":"The time-dependent bias and its effect on extra length of stay due to nosocomial infection","volume":"14","author":"Barnett","year":"2011","journal-title":"Value Health."},{"key":"B17","unstructured":"AllignolA\n          Package \u2018etm.\u2019 CRAN.2015"},{"key":"B18","unstructured":"AllignolR\n          Package \u2018 Mvna \u2019 - Nelson-Aalen Estimator of the Cumulative Hazard in Multistate Models.2015"},{"key":"B19","unstructured":"About JANIS.2020"},{"key":"B20","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement Document.","author":"Franklin","year":"2012"},{"key":"B21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/bimj.201000146","article-title":"Application of multistate models in hospital epidemiology: advances and challenges","volume":"53","author":"Beyersmann","year":"2011","journal-title":"Biom J."},{"key":"B22","first-page":"196","article-title":"Average length of stay in hospitals","volume-title":"Health at a Glance 2019: OECD Indicators.","author":"James","year":"2019"},{"key":"B23","unstructured":"32370763CHOosing Interventions that are Cost Effective (WHO-CHOICE) - Country-Specific Unit Costs.2011"},{"key":"B24","unstructured":"PPP Conversion Factor, GDP (LCU per international $)2020"},{"key":"B25","unstructured":"GDP Deflator (base year varies by country)2020"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","article-title":"Adjusting for inflation and currency changes within health economic studies","volume":"22","author":"Turner","year":"2019","journal-title":"Value Health."},{"key":"B27","volume-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003.","author":"Tan-Torres Edejer","year":"2017"},{"key":"B28","unstructured":"The Legal Side of Open Source."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jclinepi.2011.04.004","article-title":"Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices","volume":"64","author":"Bottle","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2020.562427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T04:41:00Z","timestamp":1606452060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2020.562427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2020.562427"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2020.562427","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"article-number":"562427"}}